Healthcare >> Analyst Interviews >> May 22, 2001

Outlook For Specialty Pharmaceuticals: Christopher Sylvester – Ubs Warburg, Llc

CHRISTOPHER J. SYLVESTER is an Associate Director in the healthcare group of UBS Warburg Equity Research. He covers the pharmaceutical industry, with special emphasis on mid-cap pharmaceutical companies. Prior to joining UBS Warburg, Mr. Sylvester was the mid-cap pharmaceutical analyst at PaineWebber Incorporated and before that Mr. Sylvester assisted in covering the pharmaceutical industry. Mr. Sylvester holds an MS in Biotechnology from the College of William & Mary and a BA in Biotechnology from Bucknell University. Profile
TWST: What is your outlook for specialty pharmaceuticals in general for

the next 12-18 months? What factors are part of your assessment?

Mr. Sylvester: A lot of our work in this area is in